Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Spectrum Pharma Inc (NQ: SPPI )

3.320 USD +0.030 (+0.91%)
Streaming Delayed Price Updated: 11:21 AM EST, Mar 8, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Spectrum Pharma Inc

< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
Spectrum Pharmaceuticals Presents Twice Daily Dosing Data for Poziotinib at the ESMO TAT Virtual Congress 2021
Spectrum Pharmaceuticals Presents Twice Daily Dosing Data for Poziotinib at the ESMO TAT Virtual Congress 2021 
From Business Wire News Releases
Spectrum Pharmaceuticals Announces Poster Presentation at Upcoming Miami Breast Cancer Conference
Spectrum Pharmaceuticals Announces Poster Presentation at Upcoming Miami Breast Cancer Conference 
From Business Wire News Releases
Spectrum Pharmaceuticals Announces Two Presentations at Upcoming ESMO TAT Virtual Congress 2021
Spectrum Pharmaceuticals Announces Two Presentations at Upcoming ESMO TAT Virtual Congress 2021 
From Business Wire News Releases
Spectrum Pharmaceuticals to Participate in Guggenheim Healthcare Talks 2021 Oncology Day
Spectrum Pharmaceuticals to Participate in Guggenheim Healthcare Talks 2021 Oncology Day 
From Business Wire News Releases
Spectrum Pharmaceuticals Announces Two Oral Presentations at Upcoming IASLC 2020 World Conference on Lung Cancer
Spectrum Pharmaceuticals Announces Two Oral Presentations at Upcoming IASLC 2020 World Conference on Lung Cancer 
From Business Wire News Releases
Spectrum Pharmaceuticals to Participate in Three Upcoming Investor Conferences in January
Spectrum Pharmaceuticals to Participate in Three Upcoming Investor Conferences in January 
From Business Wire News Releases
Spectrum Provides Poziotinib Update after Successful Pre-NDA Meeting with the FDA
Spectrum Provides Poziotinib Update after Successful Pre-NDA Meeting with the FDA 
From Business Wire News Releases
BeyondSpring Announces the Appointment of Dr. Jeffrey Vacirca to its Board of Directors
From GlobeNewswire News Releases
Spectrum Pharmaceuticals Appoints Nora Brennan to Board of Directors
Spectrum Pharmaceuticals Appoints Nora Brennan to Board of Directors 
From Business Wire News Releases
Spectrum Pharmaceuticals Announces Three Poster Presentations at Upcoming San Antonio Breast Cancer Symposium
Spectrum Pharmaceuticals Announces Three Poster Presentations at Upcoming San Antonio Breast Cancer Symposium 
From Business Wire News Releases
Spectrum Pharmaceuticals to Present at Two Upcoming Investor Conferences in November
Spectrum Pharmaceuticals to Present at Two Upcoming Investor Conferences in November 
From Business Wire News Releases
Spectrum Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Update
Spectrum Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Update 
From Business Wire News Releases
Spectrum Pharmaceuticals to Report Third Quarter 2020 Financial Results and Provide Corporate Update
Spectrum Pharmaceuticals to Report Third Quarter 2020 Financial Results and Provide Corporate Update 
From Business Wire News Releases
Spectrum Pharmaceuticals Announces that the FDA is Deferring its Action on the BLA for ROLONTIS® (eflapegrastim)
Spectrum Pharmaceuticals Announces that the FDA is Deferring its Action on the BLA for ROLONTIS® (eflapegrastim) 
From Business Wire News Releases
Spectrum Pharmaceuticals Presents Results in HER2 Exon 20 Insertion Mutations from Cohort 2 of the Poziotinib ZENITH20 Clinical Trial
Spectrum Pharmaceuticals Presents Results in HER2 Exon 20 Insertion Mutations from Cohort 2 of the Poziotinib ZENITH20 Clinical Trial 
From Business Wire News Releases
Spectrum Pharmaceuticals Announces Two Presentations for Poziotinib at ESMO Virtual Congress 2020
Spectrum Pharmaceuticals Announces Two Presentations for Poziotinib at ESMO Virtual Congress 2020 
From Business Wire News Releases
Spectrum Pharmaceuticals to Present at Two Upcoming Investor Conferences in September
Spectrum Pharmaceuticals to Present at Two Upcoming Investor Conferences in September 
From Business Wire News Releases
Spectrum Pharmaceuticals Reports Second Quarter 2020 Financial Results and Corporate Update
Spectrum Pharmaceuticals Reports Second Quarter 2020 Financial Results and Corporate Update 
From Business Wire News Releases
Spectrum Pharmaceuticals Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
Spectrum Pharmaceuticals Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares 
From Business Wire News Releases
Spectrum Pharmaceuticals to Report Second Quarter 2020 Financial Results and Provide Corporate Update
Spectrum Pharmaceuticals to Report Second Quarter 2020 Financial Results and Provide Corporate Update 
From Business Wire News Releases
Spectrum Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Spectrum Pharmaceuticals Announces Pricing of Public Offering of Common Stock 
From Business Wire News Releases
Spectrum Pharmaceuticals Announces Proposed Public Offering of Common Stock
Spectrum Pharmaceuticals Announces Proposed Public Offering of Common Stock 
From Business Wire News Releases
Thinking about buying stock in Spectrum Pharmaceuticals, Sohu.com, Southwest Airlines, resTORbio, or Vaxart Inc?
InvestorsObserver issues critical PriceWatch Alerts for SPPI, SOHU, LUV, TORC, and VXRT. 
From PR Newswire
Spectrum Pharmaceuticals Announces Positive Topline Results in HER2 Exon20 Insertion Mutations from Cohort 2 of the Poziotinib ZENITH20 Trial
Spectrum Pharmaceuticals Announces Positive Topline Results in HER2 Exon20 Insertion Mutations from Cohort 2 of the Poziotinib ZENITH20 Trial 
From Business Wire News Releases
Tarsus Pharmaceuticals Announces Appointment of New COO and CFO
Sesha Neervannan, PhD, to assume position of Chief Operating Officer; Leo Greenstein to assume position of Chief Financial Officer 
From PR Newswire
Spectrum Pharmaceuticals Presents Same Day Dosing Data for ROLONTIS® (eflapegrastim) at AACR Virtual Annual Meeting II
Spectrum Pharmaceuticals Presents Same Day Dosing Data for ROLONTIS® (eflapegrastim) at AACR Virtual Annual Meeting II 
From Business Wire News Releases
Spectrum Pharmaceuticals to Present Preclinical ROLONTIS® (eflapegrastim) Same Day Dosing Data at AACR Virtual Annual Meeting II
Spectrum Pharmaceuticals to Present Preclinical ROLONTIS® (eflapegrastim) Same Day Dosing Data at AACR Virtual Annual Meeting II 
From Business Wire News Releases
Spectrum Pharmaceuticals Appoints Lyndah K. Dreiling, M.D., MBA, as Senior Vice President, Clinical Development
Spectrum Pharmaceuticals Appoints Lyndah K. Dreiling, M.D., MBA, as Senior Vice President, Clinical Development 
From Business Wire News Releases
Spectrum Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference 2020
Spectrum Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference 2020 
From Business Wire News Releases
Spectrum Pharmaceuticals Reports First Quarter 2020 Financial Results and Pipeline Update
Spectrum Pharmaceuticals Reports First Quarter 2020 Financial Results and Pipeline Update 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.